Angela Stefanachi
Via E. Orabona 4
Bari, 70125, Italy
Bari, 70125, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Leveraging multitargeting BChE-MAO B inhibitors against microglia-related neuroinflammation: in vitro biological evaluation, structure-activity relationships, drug-like properties, and X-ray crystal complexes.
Journal: European journal of medicinal chemistry
Published: April 23, 2026
Virtual screening-guided repurposing of fluorescent probes to detect EGFR expression in renal cells.
Virtual screening-guided repurposing of fluorescent probes to detect EGFR expression in renal cells.
Journal: Bioorganic chemistry
Published: March 16, 2026
Synthesis and biological evaluation of novel fused pyridopyrimidine derivatives as topoisomerase I inhibitors and as potential antitumor agents: promising results in lung, ovary and gastric cancer.
Journal: European journal of medicinal chemistry
Published: December 29, 2025
Conformational Restriction of Designer Drugs Reveals Subtype-Selective and Biased CB2 Agonists with Neuroprotective Effects.
Journal: Journal of medicinal chemistry
Published: August 12, 2025
CC48 a new CB2R agonist/FAAH inhibitor dual drug blocks gastric cancer progression and overcomes paclitaxel resistance.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 09, 2025
One-pot assembling pyrroloquinoline quinone glucose dehydrogenase with polydopamine to overcome the reproducibility issues of layer-by-layer electrode development.
Journal: Sensors & diagnostics
Published: April 08, 2025
Playing Around the Coumarin Core in the Discovery of Multimodal Compounds Directed at Alzheimer's-Related Targets: A Recent Literature Overview.
Journal: Molecules (Basel, Switzerland)
Published: January 22, 2025
N-Adamantyl-1-alkyl-4-oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as Fluorescent Probes to Detect Microglia Activation through the Imaging of Cannabinoid Receptor Subtype 2 (CB2R).
Journal: Journal of medicinal chemistry
Published: June 27, 2024
DeLA-DrugSelf: Empowering multi-objective de novo design through SELFIES molecular representation.
Journal: Computers in biology and medicine
Published: February 03, 2024
Development of Fluorescent 4-[4-(3H-Spiro[isobenzofuran-1,4'-piperidin]-1'-yl)butyl]indolyl Derivatives as High-Affinity Probes to Enable the Study of σ Receptors via Fluorescence-Based Techniques.
Journal: Journal of medicinal chemistry
Published: March 15, 2023
Multicomponent Reaction-Assisted Drug Discovery: A Time- and Cost-Effective Green Approach Speeding Up Identification and Optimization of Anticancer Drugs.
Journal: International journal of molecular sciences
Published: January 26, 2023
Development of N-(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase.
Journal: Journal of medicinal chemistry
Published: December 21, 2022
Last Updated: 09/26/2026